NEW YORK, Jan. 5, 2024 /PRNewswire/ — The active pharmaceutical ingredients market is expected to grow by USD 86.47 billion from 2023 to 2028. In addition, the momentum of the market will progress at a CAGR of 6.73% during the forecast period, according to Technavio Research. The market is segmented by manufacturing type (captive APIs and contract APIs), type (innovative APIs and generic APIs), and geography (Asia, North America, Europe, and the Rest of World (ROW)). Asia is estimated to contribute 52% to the growth of the global market during the forecast period. Indian companies have developed a very high level of competence in the manufacture of pharmaceutical products that comply with good manufacturing practice standards, having fulfilled regulatory needs by US and European-based generic drug manufacturers to commercially market their bulk products at large scale.

This report offers an up-to-date analysis of the current market scenario, the latest trends and drivers, and the overall market environment. Read a Free PDF Sample Report

Company Profile:

AbbVie Inc., Amneal Pharmaceuticals Inc., Apotex Inc., Aurobindo Pharma Ltd., Cadila Pharmaceuticals Ltd., Cambrex Corp., Cipla Ltd., Dr Reddys Laboratories Ltd., GlaxoSmithKline Plc, Indena S.p.A., INTERNATIONAL CHEMICAL INVESTORS S.E., Koninklijke DSM NV, Lupin Ltd., Novartis AG, Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Thermo Fisher Scientific Inc., and Viatris Inc.

AbbVie Inc. – The company offers active pharmaceutical ingredients such as organometallic and gaseous HCl.

To gain access to more company profiles available with Technavio, buy the report!

Active Pharmaceutical Ingredients Market: Segmentation Analysis

The market share growth by the captive APIs segment will be significant during the forecast period. The global market for pharmaceutical ingredients has been substantially stimulated by an increase in the use of healthcare services.

Learn about the contribution of each segment summarized in concise infographics and thorough descriptions. View a Free PDF Sample Report

Active Pharmaceutical Ingredients Market: Market Dynamics

Key Driver

• Increasing the number of type II drug master files (DMF)
• Evolving API manufacturing scenario in developing scenario
• Growing need to focus on core competencies

The increasing number of type II drug master files (DMF) is the key factor driving the market growth. As pharmaceutical companies increasingly rely on API producers to outsource bulk actives for the production of generic drugs as well as high-end, highly complex patented pharmaceuticals, the market for active medicinal ingredients is rapidly developing.

Major Trend

The increasing geriatric population is an emerging trend shaping the market growth.

Identify key trends, drivers, and challenges in the market. Download a sample report to gain access to this information.

Related Reports:

The herbal medicine market size is estimated to grow at a CAGR of 5.96% between 2022 and 2027 and the herbal medicine market size forecast is set to increase by USD 36,636.05 million. 

The compounding pharmacy market size is estimated to grow at a CAGR of 2.18% between 2022 and 2027. The market size is forecast to increase by USD 1,682.04 million.

What are the key data covered in this active pharmaceutical ingredients market report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the growth of the active pharmaceutical ingredients market between 2023 and 2028.
• Precise estimation of the active pharmaceutical ingredients market size and its contribution to the market in focus on the parent market
• Accurate predictions about upcoming trends and changes in consumer behavior
• Growth of the active pharmaceutical ingredients market across North America, Europe, Asia, and ROW
• A thorough analysis of the market’s competitive landscape and detailed information about companies
• Comprehensive analysis of factors that will challenge the growth of active pharmaceutical ingredients market companies.

ToC:

Executive Summary

Market Landscape

Market Sizing

Historic Market Sizes

Five Forces Analysis

Market Segmentation by Manufacturing Type

Market Segmentation by Type

Market Segmentation by Geography

Customer Landscape

Geographic Landscape

Drivers, Challenges, & Trends

Company Landscape

Company Analysis

Appendix

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com

SOURCE Technavio